Phosphate Binders Need To Show Clinical Benefit For Pre-Dialysis – Cmte.

Outcomes trials should be conducted to support the approval of phosphate binders for use in the pre-dialysis setting for kidney disease patients, FDA's Cardiovascular and Renal Drugs Advisory Committee concluded Oct. 16